EUVIMED · CrossrefJournal
Hépato-Gastro & Oncologie Digestive
ISSN 1253-7020 · JLE
Latest articles
Strengths and limitations of using data from the french national health data system in hepato-gastroenterology
Liquid biopsy and hepatocellular carcinoma: towards more personalized medicine
Swing at Beaujon hospital: memories of an hepatologist with a passion for jazz
On the use of compounded topical preparations in proctology
Management of Inflammatory Bowel Diseases in patients with history of malignancy: What to do in 2026?
Screening and management of portal hypertension in patients with advanced hepatocellular carcinoma in the era of immunotherapy
SFED position statement on endoscopic resection of non-pedunculated colorectal lesions larger than 20 mm and special cases
À retenir du n°5 Mai 2026
Management of complex pancreatic pain in pancreatic adenocarcinoma
A rectal tumor with atypical diagnosis and progression
HER2-overexpressed metastatic colorectal cancer: Towards personalized treatment?
Complications of diagnostic endoscopic ultrasound
Localized eso-gastric adenocarcinomas: new standards of treatment
Angioedema induced by angiotensin-converting enzyme inhibitor revealed by recurrent episodes of jejunitis
Sequential evolution of collagenous colitis into lymphocytic colitis and then into Crohn’s disease: about one case and review of literature
Pré-test
Post-test
Artificial intelligence in gastrointestinal endoscopy
An anthology of endoscopic images analyzed by artificial intelligence
Artificial intelligence, better than humans? From science to real life
Colonoscopy and artificial intelligence: an evolution, a revolution or an illusion?
Endoscopic surveillance of Barrett’s Esophagus: Less is more?
Management of fecal incontinence
Liver benefits of bariatric/metabolic surgery
● À retenir du n°4 Avril 2026
Phenotypic polymorphism of patients with mutations in the ferroportin gene : ferroportin disease vs. SCL40A1-related hemochromatosis
Be prepared, IBD prevalence continues to rise
The electrosurgical unit in digestive endoscopy: understanding how to optimize its use
The optimal duration of immunotherapy in advanced gastrointestinal cancers for “long-term responder” patients: current knowledge and perspectives
De-escalation in colorectal cancer surveillance, immediate application of PRODIGE 13 results
EUVIMED